Literature DB >> 29637624

Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival.

Miho Horie1,2, Pascal Salazar3, Tomohito Saito4,5,6, Matthew Binnie5, Kristy Brock7, Kazuhiro Yasufuku4,5, Sassan Azad4, Shaf Keshavjee2,5,6, Tereza Martinu5, Narinder Paul1,2.   

Abstract

Chronic lung allograft dysfunction (CLAD) is a major cause of mortality in lung transplant recipients. CLAD can be sub-divided into at least 2 subtypes with distinct mortality risk characteristics: restrictive allograft syndrome (RAS), which demonstrates increased overall computed tomography (CT) lung density in contrast with bronchiolitis obliterans syndrome (BOS), which demonstrates reduced overall CT lung density. This study aimed to evaluate a reader-independent quantitative density metric (QDM) derived from CT histograms to associate with CLAD survival. A retrospective study evaluated CT scans corresponding to CLAD onset using pulmonary function tests in 74 patients (23 RAS, 51 BOS). Two different QDM values (QDM1 and QDM2) were calculated using CT lung density histograms. Calculation of QDM1 includes the extreme edges of the histogram. Calculation of QDM2 includes the central region of the histogram. Kaplan-Meier analysis and Cox regression analysis were used for CLAD prognosis. Higher QDM values were significantly associated with decreased survival. The hazard ratio for death was 3.2 times higher at the 75th percentile compared to the 25th percentile using QDM1 in a univariate model. QDM may associate with CLAD patient prognosis.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  bronchiolitis obliterans syndrome; chronic lung allograft dysfunction; computed tomography; restrictive allograft syndrome

Mesh:

Year:  2018        PMID: 29637624     DOI: 10.1111/ctr.13233

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  4 in total

1.  Ferret Lung Transplantation Models Differential Lymphoid Aggregate Morphology Between Restrictive and Obstructive Forms of Chronic Lung Allograft Dysfunction.

Authors:  Thomas J Lynch; Bethany A Ahlers; Anthony M Swatek; Vitaly Ievlev; Albert C Pai; Leonard Brooks; Yinghua Tang; Idil A Evans; David K Meyerholz; John F Engelhardt; Kalpaj R Parekh
Journal:  Transplantation       Date:  2022-04-15       Impact factor: 5.385

2.  Quantitative Image Analysis at Chronic Lung Allograft Dysfunction Onset Predicts Mortality.

Authors:  S Samuel Weigt; Grace-Hyun J Kim; Heather D Jones; Allison L Ramsey; Olawale Amubieya; Fereidoun Abtin; Lila Pourzand; Jihey Lee; Michael Y Shino; Ariss DerHovanessian; Barry Stripp; Paul W Noble; David M Sayah; Rajan Saggar; Ian Britton; Joseph P Lynch; John A Belperio; Jonathan Goldin
Journal:  Transplantation       Date:  2022-05-23       Impact factor: 5.385

3.  Longitudinal assessment of interstitial lung disease in single lung transplant recipients with scleroderma.

Authors:  Alicia M Hinze; Cheng T Lin; Amira F Hussien; Jamie Perin; Aida Venado; Jeffrey A Golden; Francesco Boin; Robert H Brown; Robert A Wise; Fredrick M Wigley
Journal:  Rheumatology (Oxford)       Date:  2020-04-01       Impact factor: 7.580

Review 4.  Lung Transplantation: CT Assessment of Chronic Lung Allograft Dysfunction (CLAD).

Authors:  Anne-Laure Brun; Marie-Laure Chabi; Clément Picard; François Mellot; Philippe A Grenier
Journal:  Diagnostics (Basel)       Date:  2021-04-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.